Bayer has reduced its direct interest in Covestro from 24.6% to 14.2%, selling a total of 21 million shares at a price of €86.25/share. The placement volume amounted to €1.8 billion ($2.2 billion), exceeding the €1.5 billion initially envisaged, due to strong interest shown by investors. The share placement took place on 10 January after market close CET and was aimed exclusively at institutional investors.
Bayer has been divesting its stake in Covestro in stages since March 2017 as it focuses on its life sciences businesses. Bayer intends to achieve full separation from Covestro in the medium term, as previously announced.
The price of the latest placement is €19.75/share higher than the price achieved in March 2017. Bayer then reduced its stake in Covestro from 64.2% to 53.3%, selling 22 million shares and raising €1.5 billion at €66.5/share. The company reduced its stake further in June, to 44.8%, selling 17.25 million shares at €62.25/share. By September, it had raised a further €2.2 billion and reduced it’s stake in Covestro to 24.6%. The company has raised about €5.5 billion in total from Covestro shares since March.
Bayer’s material science subgroup was renamed Covestro in September 2015, and Covestro was publicly listed in October of the same year.
Credit Suisse and Goldman Sachs International acted as joint bookrunners for the latest placement, and Bayer has agreed to a 90-day lock-up period as part of the transaction.
The Bayer Pension Trust holds a separate 8.9% stake in Covestro.
By Francinia Protti-Alvarez
Source: Chemical Week
Neste Corporation’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard) as the President and CEO of Neste as of 2 November 2024, at the latest. Malinen joins Neste from Outokumpu Corporation where he has held the position of President and CEO since 2020.
Petrochemicals company Sasol has announced that CFO and executive director Hanré Rossouw will step down from his position, effective October 31. Sasol has started the process to appoint a successor. Rossouw will still oversee the publication of Sasol’s reports for the financial year ending June 30, to allow for a structured handover period.
Chemours announced its CFO Jonathan Lock has resigned from all positions within the company, according to an SEC 8-K filing on April 23. The resignation comes in the aftermath of the company announcing that Lock, former CEO Mark Newman, and principal accounting officer Camela Wisel, had been placed on administrative leave.
